个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
周四盘中交易时段,12只医疗保健类股走势
Gainers
- Vapotherm (NYSE:VAPO) shares rose 44.2% to $1.28 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 7.8 million shares, making up 2565.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $34.2 million.
- Kintara Therapeutics (NASDAQ:KTRA) stock rose 32.67% to $8.89. Kintara Therapeutics's stock is trading at a volume of 1.9 million shares as of 12:30 EST. This is 698.9% of its average full-day volume over the last 100 days. The company's market cap stands at $14.3 million.
- Vaxxinity (NASDAQ:VAXX) stock rose 29.93% to $3.4. Trading volume for this security as of 12:30 EST is 5.8 million, which is 3124.3% of its average full-day volume over the last 100 days. The company's market cap stands at $429.1 million.
- Ainos (NASDAQ:AIMD) stock rose 22.91% to $0.75. As of 12:30 EST, this security is trading at a volume of 66.9K shares, making up 11.3% of its average full-day volume over the last 100 days. The company's market cap stands at $15.0 million.
- Conformis (NASDAQ:CFMS) shares moved upwards by 17.37% to $3.29. As of 12:30 EST, this security is trading at a volume of 149.8K shares, making up 159.9% of its average full-day volume over the last 100 days. The company's market cap stands at $24.7 million.
- IN8bio (NASDAQ:INAB) shares increased by 16.67% to $2.03. Trading volume for this security as of 12:30 EST is 137.6K, which is 10.7% of its average full-day volume over the last 100 days. The company's market cap stands at $49.7 million.
Losers
- Aziyo Biologics (NASDAQ:AZYO) stock declined by 41.0% to $4.07 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 197.7K, which is 3029.4% of its average full-day volume over the last 100 days. The company's market cap stands at $56.1 million.
- Biophytis (NASDAQ:BPTS) stock declined by 36.03% to $0.43. Trading volume for Biophytis's stock is 549.2K as of 12:30 EST. This is 224.7% of its average full-day volume over the last 100 days. The company's market cap stands at $8.7 million.
- Biodesix (NASDAQ:BDSX) stock fell 26.5% to $1.47. As of 12:30 EST, Biodesix's stock is trading at a volume of 518.4K, which is 248.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $120.1 million.
- Corbus Pharmaceuticals (NASDAQ:CRBP) stock declined by 25.4% to $0.15. As of 12:30 EST, this security is trading at a volume of 11.4 million shares, making up 256.6% of its average full-day volume over the last 100 days. The company's market cap stands at $18.1 million.
- Aura Biosciences (NASDAQ:AURA) shares declined by 16.46% to $11.93. Trading volume for Aura Biosciences's stock is 810.5K as of 12:30 EST. This is 1004.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $349.9 million.
- Gelesis Holdings (NYSE:GLS) shares decreased by 16.22% to $0.31. Trading volume for Gelesis Holdings's stock is 102.1K as of 12:30 EST. This is 70.4% of its average full-day volume over the last 100 days. The company's market cap stands at $22.6 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
获胜者
- Vapotherm (NYSE:VAPO) shares rose 44.2% to $1.28 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 7.8 million shares, making up 2565.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $34.2 million.
- Kintara Therapeutics (NASDAQ:KTRA) stock rose 32.67% to $8.89. Kintara Therapeutics's stock is trading at a volume of 1.9 million shares as of 12:30 EST. This is 698.9% of its average full-day volume over the last 100 days. The company's market cap stands at $14.3 million.
- Vaxxinity (NASDAQ:VAXX) stock rose 29.93% to $3.4. Trading volume for this security as of 12:30 EST is 5.8 million, which is 3124.3% of its average full-day volume over the last 100 days. The company's market cap stands at $429.1 million.
- Ainos (NASDAQ:AIMD) stock rose 22.91% to $0.75. As of 12:30 EST, this security is trading at a volume of 66.9K shares, making up 11.3% of its average full-day volume over the last 100 days. The company's market cap stands at $15.0 million.
- Conformis (NASDAQ:CFMS) shares moved upwards by 17.37% to $3.29. As of 12:30 EST, this security is trading at a volume of 149.8K shares, making up 159.9% of its average full-day volume over the last 100 days. The company's market cap stands at $24.7 million.
- IN8bio (NASDAQ:INAB) shares increased by 16.67% to $2.03. Trading volume for this security as of 12:30 EST is 137.6K, which is 10.7% of its average full-day volume over the last 100 days. The company's market cap stands at $49.7 million.
- Vapotherm 纽约证券交易所代码:VAPO)股价在周四的例行交易中上涨了44.2%,至1.28美元。截至美国东部标准时间 12:30,该证券的交易量为780万股,占过去100天平均全日交易量的2565.9%。他们已发行股票的市值为3,420万美元。
- 金塔拉疗法 纳斯达克股票代码:KTRA)股价上涨32.67%,至8.89美元。截至美国东部标准时间 12:30,Kintara Therapeutics的股票交易量为190万股。这是过去100天平均全天交易量的698.9%。该公司的市值为1430万美元。
- Vaxxinity 纳斯达克股票代码:VAXX)股价上涨29.93%,至3.4美元。截至美国东部标准时间 12:30,该证券的交易量为580万笔,占过去100天平均全天交易量的3124.3%。该公司的市值为4.291亿美元。
- 艾诺斯 纳斯达克股票代码:AIMD)股价上涨22.91%,至0.75美元。截至美国东部标准时间 12:30,该证券的交易量为66.9万股,占过去100天平均全日交易量的11.3%。该公司的市值为1,500万美元。
- Conformis 纳斯达克股票代码:CFMS)股价上涨了17.37%,至3.29美元。截至美国东部标准时间 12:30,该证券的交易量为149.8万股,占过去100天平均全日交易量的159.9%。该公司的市值为2470万美元。
- in8Bio 纳斯达克股票代码:INAB)的股价上涨了16.67%,至2.03美元。截至美国东部标准时间 12:30,该证券的交易量为137.6万,占过去100天平均全天交易量的10.7%。该公司的市值为4,970万美元。
Losers
失败者
- Aziyo Biologics (NASDAQ:AZYO) stock declined by 41.0% to $4.07 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 197.7K, which is 3029.4% of its average full-day volume over the last 100 days. The company's market cap stands at $56.1 million.
- Biophytis (NASDAQ:BPTS) stock declined by 36.03% to $0.43. Trading volume for Biophytis's stock is 549.2K as of 12:30 EST. This is 224.7% of its average full-day volume over the last 100 days. The company's market cap stands at $8.7 million.
- Biodesix (NASDAQ:BDSX) stock fell 26.5% to $1.47. As of 12:30 EST, Biodesix's stock is trading at a volume of 518.4K, which is 248.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $120.1 million.
- Corbus Pharmaceuticals (NASDAQ:CRBP) stock declined by 25.4% to $0.15. As of 12:30 EST, this security is trading at a volume of 11.4 million shares, making up 256.6% of its average full-day volume over the last 100 days. The company's market cap stands at $18.1 million.
- Aura Biosciences (NASDAQ:AURA) shares declined by 16.46% to $11.93. Trading volume for Aura Biosciences's stock is 810.5K as of 12:30 EST. This is 1004.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $349.9 million.
- Gelesis Holdings (NYSE:GLS) shares decreased by 16.22% to $0.31. Trading volume for Gelesis Holdings's stock is 102.1K as of 12:30 EST. This is 70.4% of its average full-day volume over the last 100 days. The company's market cap stands at $22.6 million. See Also:
- Azio Biologics 纳斯达克股票代码:AZYO)股价在周四的例行交易中下跌了41.0%,至4.07美元。截至美国东部标准时间 12:30,该证券的交易量为197.7万,占过去100天平均全天交易量的3029.4%。该公司的市值为5610万美元。
- 生物植物 纳斯达克股票代码:BPTS)股价下跌36.03%,至0.43美元。截至美国东部标准时间 12:30,Biophytis股票的交易量为54.92万。这是过去100天平均全天交易量的224.7%。该公司的市值为870万美元。
- Biodesix 纳斯达克股票代码:BDSX)股价下跌26.5%,至1.47美元。截至美国东部标准时间 12:30,Biodesix的股票交易量为518.4万,是过去100天全天平均交易量的248.6%。他们的已发行股票的市值为1.201亿美元。
- 柯布斯制药 纳斯达克股票代码:CRBP)股价下跌25.4%,至0.15美元。截至美国东部标准时间 12:30,该证券的交易量为1140万股,占过去100天平均全日交易量的256.6%。该公司的市值为1810万美元。
- 奥拉生物科学 纳斯达克股票代码:AURA)股价下跌16.46%,至11.93美元。截至美国东部标准时间 12:30,Aura Biosciences股票的交易量为81.05万。这是过去 100 天平均全天交易量的 1004.9%。他们已发行股票的市值为3.499亿美元。
- 吉莱西斯控股公司 纽约证券交易所代码:GLS)股价下跌16.22%,至0.31美元。截至美国东部标准时间 12:30,Gelesis Holdings股票的交易量为102.1万。这是过去 100 天平均全天交易量的 70.4%。该公司的市值为2260万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!